ArthNow Logo
ArthNow
•1 min read•
✦Reported by The Economic Times

AMFI Reshuffle: Lenskart Solutions, Zydus Lifesciences among 5 midcap stocks that may get upgraded to largecap

AMFI Reshuffle: Lenskart Solutions, Zydus Lifesciences among 5 midcap stocks that may get upgraded to largecap
Source: The Economic Times

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Lenskart Solutions and Zydus Lifesciences are among five midcap stocks that may get upgraded to largecap status by AMFI in H1 CY27.
  • ✓Nuvama Institutional Equities predicted this shift based on rising market-cap levels.
  • ✓Bosch, Lodha Developers, and LG Electronics India also showed potential to move up in the upcoming semi-annual rejig.

Story at a Glance

Category
Indian Markets
Reported By
The Economic Times
Reading Speed
1 Minute(s)
Market Focus
India Economy

These five midcap stocks may soon get upgraded to largecap segment by the Association of Mutual Funds in India (AMFI) in its Semi-Annual rejig in H1 CY27, according to a prediction by Nuvama Institutional Equities.

Based on current average market-cap levels, AMFI may increase the large-cap cut-off to approximately Rs 1.12 lakh crore (compared to Rs 1.06 lakh crore as of June 2026) and the mid-cap threshold to be around Rs 36,700 crore (compared to Rs 33,600 crore as of June 2026).

Bosch, a midcap stock with a market cap of Rs 1.46 lakh crore, may get largecap status in H1 CY27.

Zydus Lifesciences, a borderline midcap stock with a market cap of Rs 1.21 lakh crore, may get largecap status in H1 CY27.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

The Economic Times

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.